6 ) 2) No information was given regarding the amount of SAD exposure for either the CAF-exposed or control infants; 3) The benefit pertaining to cerebral palsy and neurodevelopmental impairment is apparently ephemeral - for both conditions the benefit was considered weakly significant at 18–21 months of age, but was absent in the same cohort at 5 yrs 48 .
1
—
—